Weesp, Netherlands

Guustaaf Jm Van Scharrenburg


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guustaaf Jm Van Scharrenburg: Innovator in Triazine Derivatives

Introduction

Guustaaf Jm Van Scharrenburg is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on triazine derivatives. His research focuses on the development of compounds that serve as ligands for human adenosine-A3 receptors.

Latest Patents

Van Scharrenburg holds a patent for "1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors." This invention relates to a group of novel triazine derivatives that act as ligands for human adenosine-A3 receptors. The patent also covers pharmaceutical compositions that contain a pharmacologically active amount of at least one of these compounds as an active ingredient. The compounds are defined by a general formula where specific groups are represented, contributing to their unique properties.

Career Highlights

Throughout his career, Van Scharrenburg has worked with prominent companies in the pharmaceutical industry. He has been associated with Solvay Pharmaceuticals and Arqule, Inc., where he has contributed to various research and development projects. His expertise in the field has allowed him to make impactful advancements in drug development.

Collaborations

Some of his notable coworkers include Jacobus Aj Den Hartog and Jan H Reinders. Their collaborative efforts have further enhanced the research and development of innovative pharmaceutical solutions.

Conclusion

Guustaaf Jm Van Scharrenburg is a distinguished inventor whose work on triazine derivatives has the potential to influence the pharmaceutical industry significantly. His contributions, along with his collaborations, highlight the importance of innovation in developing new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…